- Filed
- Dec 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Dec 15, 2025 | 115.14M sh |
| Shares Diluted | Q2 2026 · Nov 23, 2025 | 116.7M sh |
| Shares Diluted | Q2 2026 · Nov 23, 2025 | 117.2M sh |
| Shares Diluted | Q2 2026 · Nov 24, 2024 | 118.3M sh |
| Shares Diluted | Q2 2026 · Nov 24, 2024 | 118.7M sh |
| Stock Repurchased | Q2 2026 · Nov 23, 2025 | $407.1M |
| Stock Repurchased | Q2 2026 · Nov 24, 2024 | $314.2M |
| Dividends Paid | Q2 2026 · Nov 23, 2025 | $349M |
| Dividends Paid | Q2 2026 · Nov 24, 2024 | $330.5M |
| Capex | Q2 2026 · Nov 23, 2025 | $375M |
| Capex | Q2 2026 · Nov 24, 2024 | $314.5M |
| Short Term Debt | Q2 2026 · Nov 23, 2025 | $438M |
| Short Term Debt | Q2 2026 · May 25, 2025 | $0 |
| Cash And Equivalents | Q2 2026 · Nov 23, 2025 | $224.1M |
| Cash And Equivalents | Q2 2026 · May 25, 2025 | $240M |
| Cash And Equivalents | Q2 2026 · Nov 24, 2024 | $217.3M |
| Stockholders Equity | Q2 2026 · Nov 23, 2025 | $2.08B |
| Stockholders Equity | Q2 2026 · Aug 24, 2025 | $2.23B |
| Stockholders Equity | Q2 2026 · May 25, 2025 | $2.31B |
| Stockholders Equity | Q2 2026 · Nov 24, 2024 | $2.07B |
| Stockholders Equity | Q2 2026 · Aug 25, 2024 | $2.14B |
| Stockholders Equity | Q2 2026 · May 26, 2024 | $2.24B |
| Current Liabilities | Q2 2026 · Nov 23, 2025 | $2.65B |
| Current Liabilities | Q2 2026 · May 25, 2025 | $2.25B |
| Total Liabilities | Q2 2026 · Nov 23, 2025 | $10.86B |
| Total Liabilities | Q2 2026 · May 25, 2025 | $10.28B |
| Current Assets | Q2 2026 · Nov 23, 2025 | $1.04B |
| Current Assets | Q2 2026 · May 25, 2025 | $937.7M |
| Total Assets | Q2 2026 · Nov 23, 2025 | $12.94B |
| Total Assets | Q2 2026 · May 25, 2025 | $12.59B |
| Total Assets restated | Q2 2026 · Nov 24, 2024 | $12.94B |
| Eps Diluted | Q2 2026 · Nov 23, 2025 | $2.03 |
| Eps Diluted | Q2 2026 · Nov 23, 2025 | $4.22 |
| Eps Diluted | Q2 2026 · Nov 24, 2024 | $1.82 |
| Eps Diluted | Q2 2026 · Nov 24, 2024 | $3.56 |
| Eps Basic | Q2 2026 · Nov 23, 2025 | $2.05 |
| Eps Basic | Q2 2026 · Nov 23, 2025 | $4.26 |
| Eps Basic | Q2 2026 · Nov 24, 2024 | $1.83 |
| Eps Basic | Q2 2026 · Nov 24, 2024 | $3.58 |
| Net Income | Q2 2026 · Nov 23, 2025 | $237.2M |
| Net Income | Q2 2026 · Nov 23, 2025 | $495M |
| Net Income | Q2 2026 · Nov 24, 2024 | $215.1M |
| Net Income | Q2 2026 · Nov 24, 2024 | $422.3M |
| Operating Income | Q2 2026 · Nov 23, 2025 | $320.4M |
| Operating Income | Q2 2026 · Nov 23, 2025 | $659.6M |
| Operating Income | Q2 2026 · Nov 24, 2024 | $292.1M |
| Operating Income | Q2 2026 · Nov 24, 2024 | $561.3M |
| Gross Profit | Q2 2026 · Nov 23, 2025 | $581.3M |
| Gross Profit | Q2 2026 · Nov 23, 2025 | $1.16B |
| Gross Profit restated | Q2 2026 · Nov 24, 2024 | $569.4M |
| Gross Profit restated | Q2 2026 · Nov 24, 2024 | $1.09B |
| Revenue | Q2 2026 · Nov 23, 2025 | $3.1B |
| Revenue | Q2 2026 · Nov 23, 2025 | $6.15B |
| Revenue | Q2 2026 · Nov 24, 2024 | $2.89B |
| Revenue | Q2 2026 · Nov 24, 2024 | $5.65B |